NCT02687139 Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma Status COMPLETED Phase NA
NCT02669914 MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors Status TERMINATED Phase PHASE2
NCT02511275 Nephrotoxicity Associated to Parenchymal Clamping During Partial Nephrectomy Using a Microdialysis Technique Status TERMINATED Phase NA
NCT02446795 Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial Status UNKNOWN Phase PHASE1/PHASE2
NCT02293980 A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001) Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02186925 A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney. Status UNKNOWN Phase N/A
NCT02143492 Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC Status COMPLETED Phase N/A
NCT02141490 Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers Status COMPLETED Phase PHASE2
NCT02118337 A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Participants With Select Advanced Malignancies Status COMPLETED Phase PHASE1/PHASE2
NCT02060370 Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC) Status COMPLETED Phase PHASE2
NCT02019693 A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer Status COMPLETED Phase PHASE2
NCT01931644 At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions Status COMPLETED Phase N/A
NCT01894607 Contrast Enhanced Intraoperative Ultrasound for Detection and Characterization of Renal Mass Undergoing Open Partial Nephrectomy Status COMPLETED Phase NA
NCT01888042 Assessing Everolimus in Fist Line Treatment on Patients With Metastatic Kidney Cancer Status TERMINATED Phase PHASE2